×
About 56,830 results

ALLMedicine™ Coronary Artery Disease Center

Research & Reviews  18,761 results

Androgenic steroids dysregulation and the risk of coronary artery disease.
https://doi.org/10.1080/14779072.2022.2077193
Expert Review of Cardiovascular Therapy; Joury A, Alshehri M et. al.

May 19th, 2022 - Endogenous testosterone deficiency or excess anabolic-androgenic steroids (AAS) have been linked to alter the physiology of different organs in the body, more specifically the vasculature of coronary arteries. Despite the health-related concerns o...

Genetic liability to rheumatoid arthritis in relation to coronary artery disease and st...
https://doi.org/10.1002/art.42239
Arthritis & Rheumatology (Hoboken, N.J.); Yuan S, Carter P et. al.

May 19th, 2022 - To assess the causality of the associations of rheumatoid arthritis (RA) with coronary artery disease (CAD) and stroke using Mendelian randomization approach. Independent single nucleotide polymorphisms strongly associated with RA (n=70) were sele...

Phenotyping in heart failure with preserved ejection fraction: A key to find effective ...
https://doi.org/10.17219/acem/149728
Advances in Clinical and Experimental Medicine : Official... Zawadzka MM, Grabowski M et. al.

May 19th, 2022 - Heart failure with preserved ejection fraction (HFpEF) is an increasingly widespread medical condition, with excessive morbidity and mortality. Recently, for the first time in HFpEF, a reduction in the primary composite outcome of cardiovascular d...

New Insights Into Long- Versus Short-Term Dual Antiplatelet Therapy Duration in Patient...
https://doi.org/10.1161/CIRCINTERVENTIONS.121.011536
Circulation. Cardiovascular Interventions; Wang HY, Dou KF et. al.

May 19th, 2022 - The appropriate duration of dual antiplatelet therapy (DAPT) and risk-benefit ratio for long-term DAPT in patients with left main (LM) disease undergoing percutaneous coronary intervention remains uncertain. Four thousand five hundred sixty-one co...

Predictive Value of C2HEST Score for Atrial Fibrillation Recurrence Following Successfu...
https://doi.org/10.1177/00033197221102230
Angiology Levent F, Kanat S et. al.

May 19th, 2022 - The C2HEST score ((coronary artery disease (CAD) or chronic obstructive pulmonary disease (COPD) [C2, 1 point each]; hypertension [H, 1 point]; elderly [E, age ≥75 years, 2 points]; systolic heart failure [S, 2 points]; thyroid disease [T, hyperth...

see more →

Guidelines  51 results

ACR Appropriateness Criteria® Chronic Chest Pain-High Probability of Coronary Artery Di...
https://doi.org/10.1016/j.jacr.2022.02.021
Journal of the American College of Radiology : JACR; , Litmanovich D et. al.

May 14th, 2022 - Management of patients with chronic chest pain in the setting of high probability of coronary artery disease (CAD) relies heavily on imaging for determining or excluding presence and severity of myocardial ischemia, hibernation, scarring, and/or t...

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the Amer...
https://doi.org/10.1016/j.jacc.2021.09.006
Journal of the American College of Cardiology; , Lawton JS et. al.

Dec 14th, 2021 - The guideline for coronary artery revascularization replaces the 2011 coronary artery bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, providing a patient-centric approach to guide clinicians in the treatme...

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A...
https://doi.org/10.1016/j.jacc.2021.09.005
Journal of the American College of Cardiology; , Lawton JS et. al.

Dec 14th, 2021 - The executive summary of the American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions coronary artery revascularization guideline provides the top 10 items readers should know about the gui...

Coronary artery disease surveillance among childhood, adolescent and young adult cancer...
https://doi.org/10.1016/j.ejca.2021.06.021
European Journal of Cancer (Oxford, England : 1990); van Dalen EC, Mulder RL et. al.

Aug 28th, 2021 - Coronary artery disease (CAD) is a concerning late outcome for cancer survivors. However, uniform surveillance guidelines are lacking. To harmonise international recommendations for CAD surveillance for survivors of childhood, adolescent and young...

Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230758/
The Journal of Allergy and Clinical Immunology; Ameratunga R, Longhurst H et. al.

Jun 25th, 2021 - COVID-19 has had a calamitous effect on the global community. Despite intense study, the immunologic response to the infection is only partially understood. In addition to older age and ethnicity, patients with comorbidities including obesity, dia...

see more →

Drugs  462 results see all →

Clinicaltrials.gov  887 results

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold
https://clinicaltrials.gov/ct2/show/NCT03119012

May 12th, 2022 - After the development of second generation drug-eluting stent (DES), clinical outcomes including in-stent restenosis have been dramatically improved in patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) compa...

DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold
https://clinicaltrials.gov/ct2/show/NCT03074305

May 12th, 2022 - The bioresorbable vascular scaffold (BRS) has been emerged as new therapeutic option in percutaneous coronary intervention for coronary artery disease. Although 2nd generation drug-eluting stent (DES) has enhanced the efficacy and safety of DES, H...

Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer
https://clinicaltrials.gov/ct2/show/NCT05366153

May 12th, 2022 - REDEEM-CAD is a prospective multi-centre study in which a process of evaluating the risk of coronary artery disease is studied in cancer survivors 40-70 years with chemotherapy or radiotherapy >5 years ago. The efficacy of this CAD risk evaluation...

Association of Coronary Artery Disease With Lewis and ABO Blood Group Phenotypes
https://clinicaltrials.gov/ct2/show/NCT05369702

May 11th, 2022 - Primary objective- To study the association of Lewis antigen and A, B, O blood group phenotypes with coronary artery disease patients attending the tertiary care hospital in Kerala. The secondary objective-To find the association of Lewis antigen ...

Physiologic Assessment of Coronary Stenosis Following PCI
https://clinicaltrials.gov/ct2/show/NCT03084367

May 10th, 2022 - DEFINE-PCI is a multi-center, prospective, non-significant risk study in up to 25 centers in USA and internationally. Consented subjects with CAD (Coronary Artery Disease) who undergo physiologic lesion assessment with iFR<0.90 in at least 1 coron...

see more →

News  2,541 results

Troponins May be Prognostic in Nonobstructive CAD Regardless of Microvascular Function
https://www.medscape.com/viewarticle/974202

May 18th, 2022 - The study covered in this summary was published in researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaways In patients with nonobstructive coronary artery disease (CAD), modest troponin elevations indicating mild myocard...

ISCHEMIA Substudy Data Just Don't Add Up, Cardiac Surgeons Say
https://www.medscape.com/viewarticle/974107

May 17th, 2022 - A recent ISCHEMIA trial substudy is under scrutiny from surgeons for a data discrepancy, rekindling concerns about reliance on the landmark trial data in the latest coronary revascularization guidelines. As previously reported, the main ISCHEMIA f...

FDA Approves Medtronic's Onyx Frontier Drug-Eluting Stent
https://www.medscape.com/viewarticle/973951

May 13th, 2022 - The US Food and Drug Administration (FDA) has approved the Onyx Frontier drug-eluting stent (DES) to treat patients with coronary artery disease, the device manufacturer, Medtronic, announced today. The Onyx Frontier shares the same stent platform...

Recurrent Atypical Chest Pain and Mild Shortness of Breath in a 62-Year-Old Woman
https://www.medscape.com/viewarticle/972767

May 9th, 2022 - Case Presentation A 62-year-old Hispanic woman with atypical chest pain and mild shortness of breath presents to a cardiologist as a new patient. She is noted to have recurring, fleeting, dull, and nonradiating pain over the central chest, lasting...

Genetic Test for Six Chronic Diseases Undergoing Clinical Trial
https://www.medscape.com/viewarticle/972933

Apr 29th, 2022 - A new type of genetic test known as a polygenic risk score could change the way clinicians detect and treat chronic illnesses. But to be widely used, genomic findings in large populations first need to be translated into valid clinical tests for i...

see more →

Patient Education  30 results see all →